Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

YAP1

  • Open Access
    Expression of YAP1 and TAZ in Melanoma-, Bronchial- and Breast Carcinoma Brain Metastasis: Primary vs. Relapsed Tumors
    JILL DICKE, LAURA HERO, SASKIA KUHL, ROLAND GOLDBRUNNER and MARCO TIMMER
    Anticancer Research May 2025, 45 (5) 1807-1812; DOI: https://doi.org/10.21873/anticanres.17560
  • You have access
    Implications of the Hippo Pathway Dysregulation in Uterine Leiomyosarcoma
    ANASTASIOS KYRIAZOGLOU, DIONYSIOS J. PAPACHRISTOU, MYRTO MOUTAFI, ALEXANDRA PAPAKOSTA, ALKISTIS PAPATHEODORIDI, MARIA KAPARELOU, ANNA MARIA KORAKITI, MICHALIS LIONTOS, MELETIOS ATHANASIOS DIMOPOULOS and FLORA ZAGOURI
    Anticancer Research August 2024, 44 (8) 3331-3336; DOI: https://doi.org/10.21873/anticanres.17152
  • You have access
    Higher YAP1 Levels Are Associated With Shorter Survival of Patients With Low Grade Astrocytoma
    JILL DICKE, LAURA HERO, SASKIA KUHL, LUKAS GĂ–RTZ, ROLAND GOLDBRUNNER and MARCO TIMMER
    Anticancer Research July 2024, 44 (7) 3005-3011; DOI: https://doi.org/10.21873/anticanres.17113
  • You have access
    Double Negativity for Expression of YAP1 and CDX2 Defines an Aggressive Type of Colitis-associated Cancer
    FENG YIN, HAO XIE, JINPING LAI, YUANHONG CHEN, JIXIN DONG, XUEFENG ZHANG and XIULI LIU
    Anticancer Research October 2020, 40 (10) 5411-5416; DOI: https://doi.org/10.21873/anticanres.14550
  • You have access
    Activation of YAP1 Is Associated with Poor Prognosis and Response to Taxanes in Ovarian Cancer
    WOOJIN JEONG, SANG-BAE KIM, BO HWA SOHN, YUN-YONG PARK, EUN SUNG PARK, SANG CHEOL KIM, SUNG SOO KIM, RANDY L. JOHNSON, MICHAEL BIRRER, DAVID S. L. BOWTELL, GORDON B. MILLS, ANIL SOOD and JU-SEOG LEE
    Anticancer Research February 2014, 34 (2) 811-817;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire